![](/img/cover-not-exists.png)
1694 SIDE EFFECTS OF BCG IN THE TREATMENT OF INTERMEDIATE AND HIGH RISK TA T1 PAPILLARY CARCINOMA OF THE BLADDER: RESULTS FROM EORTC GU CANCERS GROUP RANDOMIZED STUDY 30962 COMPARING 1/3 DOSE VS FULL DOSE DURING 1 OR 3 YEARS
Brausi, Maurizio, Oddens, Jorg, Sylvester, Richard, Bono, Aldo, Gontero, Paolo, Turkeri, LevenzVolume:
189
Language:
english
Journal:
The Journal of Urology
DOI:
10.1016/j.juro.2013.02.3004
Date:
April, 2013
File:
PDF, 95 KB
english, 2013